Page last updated: 2024-12-05

furfuryl mercaptan

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

furfuryl mercaptan: major flavoring agent in coffee; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7363
CHEMBL ID3560314
CHEBI ID166536
SCHEMBL ID125084
MeSH IDM0425156

Synonyms (75)

Synonym
LS-13041
CHEBI:166536
uran-2-ylmethanethiol
furan-2-yl-methanethiol
2-furfurylthiol
wln: t5oj b1sh
2-furylmethyl mercaptan
2-furylmethanethiol
furfuryl mercaptan
2-furanmethanethiol
nsc41142
nsc-41142
furfuryl thiol
98-02-2
usaf b-58
ai3-36709
fema no. 2493
2-furfurylmercaptan
einecs 202-628-2
(2-furanyl)methylmercaptan
nsc 41142
2-(mercaptomethyl)furan
furfuryl mercaptan (natural)
brn 0383594
alpha-furfuryl mercaptan
inchi=1/c5h6os/c7-4-5-2-1-3-6-5/h1-3,7h,4h
furfuryl mercaptan, >=97%, fg
2-furanmethanethiol, 98%
FT-0668911
F0077
furan-2-ylmethanethiol
STK802294
AKOS000119240
A845789
2-furanylmethanethiol
fufuryl mercaptan
unii-29w096tcpg
29w096tcpg ,
5-17-03-00351 (beilstein handbook reference)
175236-33-6
FT-0626575
FT-0626578
furfuryl mercaptan [fhfi]
furfuryl mercaptan [fcc]
furfurylmercaptan
nsc 41142-d2
furfuryl-mercaptan
2-furylmethylmercaptan
furanylmethyl mercaptan
furylmethanethiol
SCHEMBL125084
2-furanmethanthiol
2-mercaptomethylfuran
.alpha.-furfuryl mercaptan
dtxcid4031227
dtxsid7052654 ,
cas-98-02-2
NCGC00357144-01
tox21_303886
J-640072
Q-100003
CHEMBL3560314
mfcd00003254
F0001-2311
2-furanmethanethiol, analytical standard
furfuryl mercaptan, natural, 98%, fg
2-furfuryl mercaptan
fema 2493
Q5509474
n-alpha-t-boc-l-glutaminedicyclohexylammoniumsalt
E78916
STARBLD0016618
19980-20-2
EN300-19031
(furan-2-yl)methanethiol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
heteroareneA heterocyclic compound formally derived from an arene by replacement of one or more methine (-C=) and/or vinylene (-CH=CH-) groups by trivalent or divalent heteroatoms, respectively, in such a way as to maintain the continuous pi-electron system characteristic of aromatic systems and a number of out-of-plane pi-electrons corresponding to the Hueckel rule (4n+2).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency57.80670.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency68.58960.000221.22318,912.5098AID1259243; AID1259247
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency37.93190.001022.650876.6163AID1224838; AID1224839
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency25.82120.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency23.85480.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency27.30600.001530.607315,848.9004AID1224841
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency46.91810.057821.109761.2679AID1159526; AID1159528
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (37.50)29.6817
2010's5 (20.83)24.3611
2020's10 (41.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.72 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index4.69 (4.65)
Search Engine Demand Index49.01 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (37.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]